Registration for a live webinar on 'Innovations in antibiotic discovery: combating resistant infections' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Part 1 – Introduction and Control
-
1. Introduction to neglected tropical diseases
- Prof. David Molyneux, CMG
-
2. Eradication, elimination and control of neglected tropical diseases
- Prof. David Molyneux, CMG
-
4. Neglected tropical diseases and environment, climate change and ecology
- Prof. Jürg Utzinger
-
5. Neglected tropical diseases (NTDs) and vector control
- Prof. Charles Wondji
-
6. Importance of communities in neglected tropical disease programmes
- Dr. Alison Krentel
-
7. Monitoring, evaluation, research, learning and adapting for NTD programs
- Ms. Katie Zoerhoff
-
8. Understanding treatment coverage in mass drug administrations
- Dr. Margaret Baker
-
9. One health challenges of zoonotic NTDs
- Prof. Eric Fèvre
-
11. NTD-related disease management, disability and Inclusion (DMDI)
- Dr. Wim H van Brakel
-
12. NTDs mapping for effective programmes 1
- Prof. B.E.B. Nwoke
-
13. NTDs mapping for effective programmes 2
- Prof. B.E.B. Nwoke
- Part 2 – NTD Diseases
-
15. Mycobacterium ulcerans disease: Buruli Ulcer
- Prof. Richard Odame Phillips
-
16. Dengue: biology, diagnosis and pathology
- Prof. Emeritus Duane J. Gubler
-
17. Dengue: epidemiology, prevention and control
- Prof. Emeritus Duane J. Gubler
-
18. Onchocerciasis (River Blindness) 1: the parasite, vector, disease and treatment
- Dr. Adrian Hopkins, MBE
-
19. Onchocerciasis (River Blindness) 2: control and elimination
- Dr. Adrian Hopkins, MBE
-
20. Schistosomiasis
- Prof. Russell Stothard
-
21. Neglected tropical diseases caused by tapeworm infections
- Dr. Wendy Harrison
-
22. Guinea worm: a case study of an eradication programme
- Prof. David Molyneux, CMG
-
23. Elimination of lymphatic filariasis: adapting to reach the end game
- Dr. Patrick Lammie
-
24. Leprosy: clinical features and treatment
- Prof. Diana N.J. Lockwood
-
25. Leprosy: epidemiology, pathology, immunology, prevention of disability and stigma
- Prof. Diana N.J. Lockwood
-
26. Visceral leishmaniasis control
- Dr. Koert Ritmeijer
-
27. Overview of trachoma Part 1
- Dr. Paul Emerson
-
28. Overview of trachoma Part 2
- Dr. Paul Emerson
-
29. Eliminating human rabies deaths: rabies as a disease and a global burden
- Prof. Sarah Cleaveland, OBE, FRS
-
30. Eliminating human rabies deaths: targeting the elimination of rabies
- Prof. Sarah Cleaveland, OBE, FRS
-
31. Human African trypanosomiasis
- Prof. Susan Welburn
-
32. Chagas disease
- Prof. Peter Hotez
-
33. Food-borne trematodes
- Prof. Russell Stothard
-
34. Yaws: past and present eradication efforts
- Prof. Oriol Mitjà
-
35. Tropical snakebite
- Prof. Robert Harrison
-
36. Introduction to podoconiosis
- Prof. Gail Davey
-
37. Scabies
- Prof. Andrew Steer
-
38. Mycetoma
- Prof. Ahmed Hassan Fahal
-
39. Loiasis: African eye worm
- Dr. Louise A. Kelly-Hope
- Part 3 – Enteric Protozoan Parasites
-
40. The ‘neglected enteric protists’: Cryptosporidium, Giardia and Entamoeba
- Prof. Sitara Ajjampur
-
41. Cryptosporidium and cryptosporidiosis
- Dr. Kevin Tyler
-
42. Toxoplasma gondii
- Prof. Geoff Hide
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Definitions and pathologies
- Endemic treponemal iInfections
- Epidemiology, 1948
- Geographical distribution, 2018
- Number of cases
- Distribution
- Imported cases
- Causative agents
- Pathogenesis
- Pathology (1)
- Pathology (2)
- Transmission
- Clinical presentation
- Clinical manifestations: primary yaws (1)
- Clinical manifestations: primary yaws (2)
- Differential diagnosis
- Clinical manifestations: secondary yaws
- Radiographical imaging
- Latent infection
- Clinical manifestations: tertiary yaws
- Diagnosis
- Diagnostic tests
- Non-treponemal tests
- Treponemal tests
- Rapid diagnostic tests
- Direct tests
- Macrolide resistance mutations
- Interpretation of results
- Clinical case number 1
- Clinical case number 2
- Therapy
- Antimicrobial susceptibility
- Treatment regimens
- Preferred antimicrobial regimens
- Efficacy results for azithromycin on yaws (1)
- Efficacy results for azithromycin on yaws (2)
- Efficacy results for azithromycin on yaws (3)
- Clinical response
- Serological response
- Clinical case number 3
- Clinical case number 4
- Eradication strategy
- Azithromycin for mass drug administration (MDA)
- Eradication is feasible (WHO target 2030)
- The Morges Strategy
- Criteria for interruption of yaws transmission
- Yaws program procedure for mass treatment
- Study in Papua New Guinea, 2018
- Results of study in Papua New Guinea (1)
- Results of study in Papua New Guinea (2)
- Conclusions on TCT for yaws
- Progress towards eradication (1)
- Progress towards eradication (2)
- Acknowledgements
Topics Covered
- Epidemiology, microbiology, and histopathology
- Clinical presentation
- Recent developments in diagnosis and treatment
- Strategy for eradication
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Mitjà, O. (2020, September 30). Yaws: past and present eradication efforts [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 24, 2025, from https://doi.org/10.69645/KOMW3877.Export Citation (RIS)
Publication History
- Published on September 30, 2020
Financial Disclosures
- Oriol Mitjà has no commercial/financial relationships to disclose.
Yaws: past and present eradication efforts
Published on September 30, 2020
28 min
HSTalks is pleased to grant unrestricted complimentary access to all lectures in the series Neglected Tropical Diseases. Persons not at a subscribing institution should sign up for a personal account.
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Oriol Mitjà .
I work at the Foundation for AIDS and Infectious Diseases Research in Barcelona.
Today I will talk about Yaws.
0:12
The talk will be divided in five major sections:
definition and pathology, clinical presentation,
diagnosis, therapy, and eradication strategies.
0:26
Yaws is an infectious disease caused by Treponema pallidum, subspecies pertenue.
This bacteria is spiral in shape and it is related to
other human treponemal infections like syphilis, bejel and pinta.
The human treponematosis can be differentiated by clinical manifestations,
geographic distribution and molecular diagnostic testing,
but cannot be differentiated by microscopy or serology.
0:54
Yaws was among the first public health problems addressed by
WHO in 1948 when it was established.
At that time, there were 96 endemic countries that are shadowed in gray in this map,
and about 15 million cases of yaws.
Between 1952 and 1964,
WHO led worldwide mass treatment campaigns to eradicate yaws.
Over 300 million examinations were conducted and
the number of yaws cases was reduced to 0.5 million.
But some areas were left untreated and yaws began to reemerge in the late 1970s.
1:27
Currently, 14 countries are known to be endemic in tropical regions of Africa,
Southeast Asia, and the Pacific.
Only two countries that are highlighted in green,
which are India and Ecuador,
have reported interruption of transmission.
Another 80 countries shadowed in gray have an unknown status
and need to be reassessed to determine whether transmission has been interrupted.